Harmony BioSciences' shares fall following critical short-seller report

A short-seller raised questions about the company's narcolepsy drug; Harmony "disagrees with their assertions."

Source: bizjournals.com Health Care:Biotechnology headlines - March 29, 2023 Category: Biotechnology Authors: John George Source Type: news